Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality

Completed · Not applicable

Conditions studied: Alcohol Use Disorder

In brief

State the scientific aim(s) of the study, or the hypotheses to be tested. The purpose of the current study is to evaluate the usage and acceptability of the Soberlink's blood alcohol concentration (BAC) unit in collaboration with Aware treatment to assess increased sobriety within patients suffering from alcohol use disorder (AUD). The specific AIMS will be: 1. To determine the effectiveness of Soberlink's ability to increase abstinence 2. To evaluate the impact of Soberlink's device on the participant based on their quality of health and sobriety. 3. To evaluate the extent to which need for higher levels of follow-up care and treatment is reduced for individuals who have had access to the Soberlink device.

Key facts

Study ID

NCT04380116

Run by

Yale University

People needed

96

Starts

2020-06-29

Expected to finish

2022-05-01

Last updated by the study team

2023-05-26

Who can join

Age: 21 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• are at least 21 years old,
• currently enrolled at Aware In home treatment,
• Primary or secondary DSM-5 diagnosis of alcoholism use disorder (AUD).

You may not qualify if…

• Current suicide or homicide risk,
• meet criteria for DSM-IV current psychotic disorder, or bipolar disorder,
• does not have phone access with text message capabilities
• Unable to read or understand English,
• Unable to complete the study because of anticipated incarceration or move,
• Life-threatening or unstable medical problems,
• No course of current or pending legal action,
• Soberlink results being used for child custody or legal circumstance.

Where it is running

• Aware Recovery Care — North Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.